Order Article Reprints

Harper TA, Bacot SM, Fennell CJ, Matthews RL, Zhu C, Yue P, Benton A, Friedman D, Akue A, KuKuruga MA, et al. IL-10 Signaling Elicited by Nivolumab-Induced Activation of the MAP Kinase Pathway Does Not Fully Contribute to Nivolumab-Modulated Heterogeneous T Cell Responses. International Journal of Molecular Sciences. 2021; 22(21):11848. https://doi.org/10.3390/ijms222111848

Harper, Taylor A., Silvia M. Bacot, Christie Jane Fennell, Rebecca L. Matthews, Christina Zhu, Peng Yue, Alexander Benton, Devira Friedman, Adovi Akue, Mark A. KuKuruga, and et al. 2021. "IL-10 Signaling Elicited by Nivolumab-Induced Activation of the MAP Kinase Pathway Does Not Fully Contribute to Nivolumab-Modulated Heterogeneous T Cell Responses" International Journal of Molecular Sciences 22, no. 21: 11848. https://doi.org/10.3390/ijms222111848

Harper, T. A., Bacot, S. M., Fennell, C. J., Matthews, R. L., Zhu, C., Yue, P., Benton, A., Friedman, D., Akue, A., KuKuruga, M. A., Lee, S., Wang, T., & Feldman, G. M. (2021). IL-10 Signaling Elicited by Nivolumab-Induced Activation of the MAP Kinase Pathway Does Not Fully Contribute to Nivolumab-Modulated Heterogeneous T Cell Responses. International Journal of Molecular Sciences, 22(21), 11848. https://doi.org/10.3390/ijms222111848